Meet the new members of the CRG team with a background in Primary Care, Gastroenterology, Oncology and Surgery. Their expertise will be invaluable to our work in OG cancer. #NOGCA #OesophagealGastricCancer buff.ly/adxYVBy @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social

🎤 UK Oesophago-Gastric Cancer Pathway Day. Olivia O’Connor, NOGCA Clinical Fellow, will be presenting key findings from 2025 State of the Nation report and our new quality-improvement intervention to support Cancer Alliances in reducing time from diagnosis to treatment buff.ly/s8eGSGA

Excited to announce that #NOGCA will be introducing a new Quality Improvement (QI) Initiative in January 2026. We're committed to enhancing standards and outcomes in OG cancer care buff.ly/9kPdoxO #OesophagealGastricCancer @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social

👋 Meet the #NOGCA team! This month, we're delighted to introduce Tom Crosby, Clinical Co-Lead (RCR) Championing the crucial role of imaging and radiotherapy in improving outcomes and the patient journey within #NOGCA framework. Learn more about the team buff.ly/LjnWfDQ

📊 Our latest NOGCA Quarterly Data Dashboard is LIVE! See data quality insights for better OG cancer care. Explore now: buff.ly/bBPyfJc
#NOGCA #OesophagealGastricCancer @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social

Thank you to all those who came to say hello to us at AUGIS last week buff.ly/rpbZB1g #NOGCA #OesophagealGastricCancer @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social

We are at AUGIS Annual Scientific Meeting 2025 this week, we look forward to connecting with you all there web-eur.cvent.com/event/fab902...
#NOGCA #OesophagealGastricCancer @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social

NOGCA will take part of the NATCAN webinar on the SotN this 13th OCT buff.ly/aMRjEGc #OesophagealGastricCancer @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social

💊 Over half of people with stage 1–3 OG cancer in England received curative treatment. The report shares insights into treatment patterns and care pathways. 🩺https://www.nogca.org.uk/reports @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social

⏳ The median time from diagnostic endoscopy to treatment for OG cancer was 64 days in England. The report highlights regional variation and areas for pathway improvement. 📈https://www.nogca.org.uk/reports @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social #NOGCA

🚨 Data show 1 in 5 people with OG cancer in England were diagnosed via emergency admission. The report explores patterns and opportunities for earlier diagnosis. 🏥https://buff.ly/PBBdTVN @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social #NOGCA #OesophagealGastricCancer

📘 The 2025 NOGCA State of the Nation Report is now live. It covers OG cancer care and outcomes in England and Wales. Read it at buff.ly/PBBdTVN
@natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social
#NOGCA #OesophagealGastricCancer

📢 The 2025 NOGCA State of the Nation Report launches 11 Sept. It highlights patterns of OG cancer care in England and Wales. Stay tuned for key findings. buff.ly/qrY112z @NATCAN_news @RCS_news @HQIP #NOGCA #OesophagealGastricCancer